Home
Fosun Pharma

Fosun Pharma Market Share Analysis for June 2026

上海复星医药集团（“复星医药”，股票代码：600196.sh，02196.hk）成立于1994 年，是一家植根中国、创新驱动的全球化医药健康产业集团，直接运营的业务包括制药、医疗器械与医学诊断、医疗健康服务，并通过参股国药控股覆盖到医药商业领域。

Health > Biotechnology and Pharmaceuticals

Domainfosunpharma.com

Year Founded1994

Employees> 10001

Annual Revenue> $1B

Fosun Pharma

Fosun Pharma (including company regionals)

fosunpharma.com

See more website traffic and engagement information

Fosun Pharma Revenue up to June 2026 is > 1B

revenue generated by Fosun Pharma top domains

Fosun Pharma top domains revenue over 3 years

Revenue for Fosun Pharma top domains

fosunpharma.com> 1B

See more with Sales Intelligence

Fosun Pharma Stock price in June 2026

Fosun Pharma stock is traded under the ticker #600196. Below you can review Fosun Pharma stock performance in the past 12 months up to June 2026

Total visits to Fosun Pharma's top domains

Understand Fosun Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

fosunpharma.com29.6K

See more with Sales Intelligence

Avg. visit duration in Fosun Pharma's top domains

Analyze Fosun Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

fosunpharma.com00:01:35

See more with Sales Intelligence

Avg. pageviews on Fosun Pharma's top domains

See how Fosun Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

fosunpharma.com3.07

See more with Sales Intelligence

Fosun Pharma top competitors by domain

Top similar sites in June 2026, ranked by their affinity

blau.comCompany NameBlau FarmacêuticaEmployees1001 - 5000HQBrazil, CotiaAnnual revenue$25M - $50MTotal visits30.9KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Fosun Pharma

These are the website technologies, by industry, used by Fosun Pharma top domains

Mobile (3)

Meta Viewport

Advertising (2)

PubMatic

Conversion & Analytics (2)

Baidu Analytics

Widget (2)

FancyBox

More Technologies

3

See all

News & Signals from Fosun Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFosun Pharma Group is developing AR1001 on Apr 1st '26.AriBio granted Fosun Pharma an exclusive worldwide option (excluding Korea, the Middle East, and Latin America) to develop, manufacture, and commercialize AR1001, a Phase III once-daily oral PDE-5 inhibitor for Alzheimer's disease (AD) being evaluated in the global POLARIS-AD trial.

NewsFosun Pharma Group hired Wang as executive president and chairman of the global R&D center on Jan 1st '23.Wang joined Fosun Pharma in January 2023 and has served as executive president and chairman of the global R&D center.